过去一年中添加的文章，按日期排序

EE88 Cost-Effectiveness of Apixaban Compared to Warfarin, Dabigatran and Rivaroxaban in Patients with Nonvalvular Atrial Fibrillation: Results for High-Risk Patient …

C Spalding, B Mountford… - Value in …, 2024 - valueinhealthjournal.com
27 天前 - … This analysis assesses the cost-effectiveness of tivozanib and sorafenib for aRCC
patients from a US commercial payer perspective. Methods: A 3-state partitioned survival …
相关文章

Safety and efficacy of oral anticoagulants in extreme weights

J Chin-Hon, L Davenport, J Huang, M Akerman… - Thrombosis …, 2023 - Elsevier
290 天前 - … Our aim is to evaluate the safety and efficacy of DOACs in underweight and obese
patients compared to warfarin. The primary endpoints include incidence of thromboembolic …
相关文章 所有 5 个版本